Hypermethylation of GpG islands in the promoter region of p15INK4b in acute promyelocytic leukemia represses p15INK4b expression and correlates with poor prognosis

L. Teofili, M. Martini, M. Luongo, D. Diverio, G. Capelli, M. Breccia, F. Lo Coco, G. Leone, L. M. Larocca

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

We evaluated the methylation status of p15 gene in a series of 65 patients with newly diagnosed acute promyelocytic leukemia (APL) receiving homogeneous treatment. Moreover, in 32 of them, the methylation status of p15 gene was correlated to the p15 m-RNA expression. In total, 31 patients had no p15 methylation (U group). An abnormal methylation pattern was found in 34 patients: in seven of these patients only methylated DNA was detected (M group), while in the remaining 27 patients (M/U group), both methylated and unmethylated DNA were amplified. Patients from M group showed a higher incidence of relapses and a lower disease-free survival (DSF) with respect to patients from U and M/U groups (29, 64 and 79% at 5 years for M, U/M and U patients, respectively, P = 0.03), while p15 methylation had no impact on overall survival. The p15 expression was detectable in all patients with unmethylated DNA, in none of patients with fully methylated DNA and in 60% of patients with partially methylated DNA. The DFS estimate at 5 years for p15-negative patients was significantly lower than that of p15-positive patients (P = 0.03). These data confirm that the presence of p15 methylation negatively influences the prognosis of APL, mainly when it represses the p15 gene transcription.

Original languageEnglish
Pages (from-to)919-924
Number of pages6
JournalLeukemia
Volume17
Issue number5
DOIs
Publication statusPublished - May 1 2003

Fingerprint

Acute Promyelocytic Leukemia
Islands
Genetic Promoter Regions
Methylation
DNA
guanylyl-(3'-5')-guanosine
Genes
Disease-Free Survival

Keywords

  • Acute promyelocytic leukemia
  • Cyclin-dependent kinase inhibitors
  • Epigentic changes

ASJC Scopus subject areas

  • Hematology
  • Cancer Research

Cite this

Hypermethylation of GpG islands in the promoter region of p15INK4b in acute promyelocytic leukemia represses p15INK4b expression and correlates with poor prognosis. / Teofili, L.; Martini, M.; Luongo, M.; Diverio, D.; Capelli, G.; Breccia, M.; Lo Coco, F.; Leone, G.; Larocca, L. M.

In: Leukemia, Vol. 17, No. 5, 01.05.2003, p. 919-924.

Research output: Contribution to journalArticle

Teofili, L. ; Martini, M. ; Luongo, M. ; Diverio, D. ; Capelli, G. ; Breccia, M. ; Lo Coco, F. ; Leone, G. ; Larocca, L. M. / Hypermethylation of GpG islands in the promoter region of p15INK4b in acute promyelocytic leukemia represses p15INK4b expression and correlates with poor prognosis. In: Leukemia. 2003 ; Vol. 17, No. 5. pp. 919-924.
@article{4820b1f41610436c98ce4a32b213374c,
title = "Hypermethylation of GpG islands in the promoter region of p15INK4b in acute promyelocytic leukemia represses p15INK4b expression and correlates with poor prognosis",
abstract = "We evaluated the methylation status of p15 gene in a series of 65 patients with newly diagnosed acute promyelocytic leukemia (APL) receiving homogeneous treatment. Moreover, in 32 of them, the methylation status of p15 gene was correlated to the p15 m-RNA expression. In total, 31 patients had no p15 methylation (U group). An abnormal methylation pattern was found in 34 patients: in seven of these patients only methylated DNA was detected (M group), while in the remaining 27 patients (M/U group), both methylated and unmethylated DNA were amplified. Patients from M group showed a higher incidence of relapses and a lower disease-free survival (DSF) with respect to patients from U and M/U groups (29, 64 and 79{\%} at 5 years for M, U/M and U patients, respectively, P = 0.03), while p15 methylation had no impact on overall survival. The p15 expression was detectable in all patients with unmethylated DNA, in none of patients with fully methylated DNA and in 60{\%} of patients with partially methylated DNA. The DFS estimate at 5 years for p15-negative patients was significantly lower than that of p15-positive patients (P = 0.03). These data confirm that the presence of p15 methylation negatively influences the prognosis of APL, mainly when it represses the p15 gene transcription.",
keywords = "Acute promyelocytic leukemia, Cyclin-dependent kinase inhibitors, Epigentic changes",
author = "L. Teofili and M. Martini and M. Luongo and D. Diverio and G. Capelli and M. Breccia and {Lo Coco}, F. and G. Leone and Larocca, {L. M.}",
year = "2003",
month = "5",
day = "1",
doi = "10.1038/sj.leu.2402907",
language = "English",
volume = "17",
pages = "919--924",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Hypermethylation of GpG islands in the promoter region of p15INK4b in acute promyelocytic leukemia represses p15INK4b expression and correlates with poor prognosis

AU - Teofili, L.

AU - Martini, M.

AU - Luongo, M.

AU - Diverio, D.

AU - Capelli, G.

AU - Breccia, M.

AU - Lo Coco, F.

AU - Leone, G.

AU - Larocca, L. M.

PY - 2003/5/1

Y1 - 2003/5/1

N2 - We evaluated the methylation status of p15 gene in a series of 65 patients with newly diagnosed acute promyelocytic leukemia (APL) receiving homogeneous treatment. Moreover, in 32 of them, the methylation status of p15 gene was correlated to the p15 m-RNA expression. In total, 31 patients had no p15 methylation (U group). An abnormal methylation pattern was found in 34 patients: in seven of these patients only methylated DNA was detected (M group), while in the remaining 27 patients (M/U group), both methylated and unmethylated DNA were amplified. Patients from M group showed a higher incidence of relapses and a lower disease-free survival (DSF) with respect to patients from U and M/U groups (29, 64 and 79% at 5 years for M, U/M and U patients, respectively, P = 0.03), while p15 methylation had no impact on overall survival. The p15 expression was detectable in all patients with unmethylated DNA, in none of patients with fully methylated DNA and in 60% of patients with partially methylated DNA. The DFS estimate at 5 years for p15-negative patients was significantly lower than that of p15-positive patients (P = 0.03). These data confirm that the presence of p15 methylation negatively influences the prognosis of APL, mainly when it represses the p15 gene transcription.

AB - We evaluated the methylation status of p15 gene in a series of 65 patients with newly diagnosed acute promyelocytic leukemia (APL) receiving homogeneous treatment. Moreover, in 32 of them, the methylation status of p15 gene was correlated to the p15 m-RNA expression. In total, 31 patients had no p15 methylation (U group). An abnormal methylation pattern was found in 34 patients: in seven of these patients only methylated DNA was detected (M group), while in the remaining 27 patients (M/U group), both methylated and unmethylated DNA were amplified. Patients from M group showed a higher incidence of relapses and a lower disease-free survival (DSF) with respect to patients from U and M/U groups (29, 64 and 79% at 5 years for M, U/M and U patients, respectively, P = 0.03), while p15 methylation had no impact on overall survival. The p15 expression was detectable in all patients with unmethylated DNA, in none of patients with fully methylated DNA and in 60% of patients with partially methylated DNA. The DFS estimate at 5 years for p15-negative patients was significantly lower than that of p15-positive patients (P = 0.03). These data confirm that the presence of p15 methylation negatively influences the prognosis of APL, mainly when it represses the p15 gene transcription.

KW - Acute promyelocytic leukemia

KW - Cyclin-dependent kinase inhibitors

KW - Epigentic changes

UR - http://www.scopus.com/inward/record.url?scp=0038189509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038189509&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2402907

DO - 10.1038/sj.leu.2402907

M3 - Article

C2 - 12750706

AN - SCOPUS:0038189509

VL - 17

SP - 919

EP - 924

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 5

ER -